ERBB2 and breast carcinoma: Our genetic association study indicated that putative miRNAs binding site rs4900321 and rs7150025, located at the 3′-UTR of ATG2B, had an independent impact on the risk of EBC recurrence and death, particularly in HER2-positive breast cancer.